Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics.
作者信息
Costabel U, Albera C, Behr J, Cottin V, Guenther A, Richeldi L
出版信息
Respir Res. 2013;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1465-9921-14-S1-S1. Epub 2013 Apr 16.
Abstract
摘要
相似文献
1
Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics.2011年特发性肺纤维化：指南与治疗的关键更新
Respir Res. 2013;14 Suppl 1(Suppl 1):S1. doi: 10.1186/1465-9921-14-S1-S1. Epub 2013 Apr 16.
2
The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF.《2015年特发性肺纤维化指南：特发性肺纤维化患者管理进展中的重要篇章》
Eur Respir J. 2015 Oct;46(4):883-6. doi: 10.1183/13993003.01335-2015.
3
Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011.特发性肺纤维化：诊断和临床管理指南已从2000年基于共识的阶段发展到2011年基于证据的阶段。
Eur Respir J. 2011 Apr;37(4):743-6. doi: 10.1183/09031936.00017711.
4
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary.《特发性肺纤维化诊断与管理的法国实用指南：2017年更新》。总结。
Rev Mal Respir. 2017 Oct;34(8):834-851. doi: 10.1016/j.rmr.2017.07.022. Epub 2017 Sep 19.
5
[S2K guideline on diagnosis and treatment of idiopathic pulmonary fibrosis].[特发性肺纤维化诊断与治疗的S2K指南]
Pneumologie. 2013 Jun;67(6):356. doi: 10.1055/s-0033-1344177. Epub 2013 Jun 7.
6
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Full-length version.法国特发性肺纤维化诊断与管理实用指南 - 2017年更新版。完整版
Rev Mal Respir. 2017 Oct;34(8):900-968. doi: 10.1016/j.rmr.2017.07.017. Epub 2017 Sep 20.
7
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Short-length version.法国特发性肺纤维化诊断与管理实用指南——2017年更新版。简短版本。
Rev Mal Respir. 2017 Oct;34(8):852-899. doi: 10.1016/j.rmr.2017.07.019. Epub 2017 Sep 20.
8
Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics. Concluding remarks.2011年特发性肺纤维化：指南与治疗的关键更新。结束语。
Respir Res. 2013;14 Suppl 1(Suppl 1):S8. doi: 10.1186/1465-9921-14-S1-S8. Epub 2013 Apr 16.
9
[Reply].[回复]
Pneumologie. 2013 Jun;67(6):356. doi: 10.1055/s-0033-1344178. Epub 2013 Jun 7.
10
[The German IPF Guideline: national vs. international].[德国特发性肺纤维化指南：国内与国际]
Pneumologie. 2013 Feb;67(2):79-80. doi: 10.1055/s-0032-1326010. Epub 2013 Feb 11.
本文引用的文献
1
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.泼尼松、硫唑嘌呤和 N-乙酰半胱氨酸治疗肺纤维化。
N Engl J Med. 2012 May 24;366(21):1968-77. doi: 10.1056/NEJMoa1113354. Epub 2012 May 20.
2
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.特发性肺纤维化：诊断和管理的循证指南（美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布）
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
3
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.美国胸科学会/欧洲呼吸学会特发性间质性肺炎国际多学科共识分类。本美国胸科学会（ATS）和欧洲呼吸学会（ERS）的联合声明于2001年6月获ATS董事会通过，并于2001年6月获ERS执行委员会通过。
Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304. doi: 10.1164/ajrccm.165.2.ats01.
Zotero 插件